
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
Axxam is a leading provider of integrated discovery services across the life sciences industry with headquarters in Milan, Italy. Within the drug discovery disciplines, we support pharma, biotech companies, start-ups, patient foundations as well as academic groups in their journey from hit identification to lead generation, regardless of the therapeutic area and target class. Our services include assay development, high-throughput screening, using either Axxams high quality compound collections (synthetic and natural) or those provided by clients, hit validation and compound management. The same science-driven approach is also applied to identify new bioactive compounds for crop protection, animal health, food, beverage,...
Molecular biology,high throughput screening (hts),high content screening (hcs),hit characterization and profiling,cardiac safety and liability profiling,electrophysiology,assay development and optimization,small molecule library for hit identification,phenotypic assays,biochemical assays,cell-based assays,and ipsc-derived cell-based assays
Axxam operates in the Biotechnology research industry.
Axxam's revenue is 11m - 100m
Axxam has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.